Skip to main content
. 2018 Sep 26;6(10):373–383. doi: 10.12998/wjcc.v6.i10.373

Figure 1.

Figure 1

Flowchart of the study population. GC: Gastric cancer; SOX: S-1 plus oxaliplatin.1High-risk features include poorly differentiated or higher grade cancer,lymphovascular invasion, neural invasion, or <50 years of age.